These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 37486495)

  • 1. Signature-Based Computational Drug Repurposing for Amyotrophic Lateral Sclerosis.
    Papikinos T; Krokidis MG; Vrahatis A; Vlamos P; Exarchos TP
    Adv Exp Med Biol; 2023; 1424():201-211. PubMed ID: 37486495
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An Integrative Transcriptome-Wide Analysis of Amyotrophic Lateral Sclerosis for the Identification of Potential Genetic Markers and Drug Candidates.
    Park S; Kim D; Song J; Joo JWJ
    Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33809961
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transcriptional analysis reveals distinct subtypes in amyotrophic lateral sclerosis: implications for personalized therapy.
    Morello G; Cavallaro S
    Future Med Chem; 2015; 7(10):1335-59. PubMed ID: 26144267
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transcriptomics and Metabolomics in Amyotrophic Lateral Sclerosis.
    Krokidis MG
    Adv Exp Med Biol; 2020; 1195():205-212. PubMed ID: 32468479
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TBK1, a prioritized drug repurposing target for amyotrophic lateral sclerosis: evidence from druggable genome Mendelian randomization and pharmacological verification in vitro.
    Duan QQ; Wang H; Su WM; Gu XJ; Shen XF; Jiang Z; Ren YL; Cao B; Li GB; Wang Y; Chen YP
    BMC Med; 2024 Mar; 22(1):96. PubMed ID: 38443977
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induced pluripotent stem cell-based Drug Repurposing for Amyotrophic lateral sclerosis Medicine (iDReAM) study: protocol for a phase I dose escalation study of bosutinib for amyotrophic lateral sclerosis patients.
    Imamura K; Izumi Y; Banno H; Uozumi R; Morita S; Egawa N; Ayaki T; Nagai M; Nishiyama K; Watanabe Y; Hanajima R; Oki R; Fujita K; Takahashi N; Ikeda T; Shimizu A; Morinaga A; Hirohashi T; Fujii Y; Takahashi R; Inoue H
    BMJ Open; 2019 Dec; 9(12):e033131. PubMed ID: 31796494
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiomics and machine-learning identify novel transcriptional and mutational signatures in amyotrophic lateral sclerosis.
    Catanese A; Rajkumar S; Sommer D; Masrori P; Hersmus N; Van Damme P; Witzel S; Ludolph A; Ho R; Boeckers TM; Mulaw M
    Brain; 2023 Sep; 146(9):3770-3782. PubMed ID: 36883643
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Diagnostic Gene-Expression Signature in Fibroblasts of Amyotrophic Lateral Sclerosis.
    Morello G; La Cognata V; Guarnaccia M; La Bella V; Conforti FL; Cavallaro S
    Cells; 2023 Jul; 12(14):. PubMed ID: 37508548
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Small molecules targeting different cellular pathologies for the treatment of amyotrophic lateral sclerosis.
    Elmansy MF; Reidl CT; Rahaman M; Özdinler PH; Silverman RB
    Med Res Rev; 2023 Nov; 43(6):2260-2302. PubMed ID: 37243319
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Purinergic P2X
    Mckenzie ADJ; Garrett TR; Werry EL; Kassiou M
    ACS Chem Neurosci; 2022 May; 13(10):1479-1490. PubMed ID: 35512313
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exploring Multiple Sclerosis (MS) and Amyotrophic Lateral Scler osis (ALS) as Neurodegenerative Diseases and their Treatments: A Review Study.
    Deeb O; Nabulsi M
    Curr Top Med Chem; 2020; 20(26):2391-2403. PubMed ID: 32972341
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New insights into the gene expression associated to amyotrophic lateral sclerosis.
    Recabarren-Leiva D; Alarcón M
    Life Sci; 2018 Jan; 193():110-123. PubMed ID: 29241710
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A computational biology approach to identify potential protein biomarkers and drug targets for sporadic amyotrophic lateral sclerosis.
    Kumar R; Malik MZ; Thanaraj TA; Bagabir SA; Haque S; Tambuwala M; Haider S
    Cell Signal; 2023 Dec; 112():110915. PubMed ID: 37838312
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Muscle histone deacetylase 4 upregulation in amyotrophic lateral sclerosis: potential role in reinnervation ability and disease progression.
    Bruneteau G; Simonet T; Bauché S; Mandjee N; Malfatti E; Girard E; Tanguy ML; Behin A; Khiami F; Sariali E; Hell-Remy C; Salachas F; Pradat PF; Fournier E; Lacomblez L; Koenig J; Romero NB; Fontaine B; Meininger V; Schaeffer L; Hantaï D
    Brain; 2013 Aug; 136(Pt 8):2359-68. PubMed ID: 23824486
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SRSF1-dependent inhibition of C9ORF72-repeat RNA nuclear export: genome-wide mechanisms for neuroprotection in amyotrophic lateral sclerosis.
    Castelli LM; Cutillo L; Souza CDS; Sanchez-Martinez A; Granata I; Lin YH; Myszczynska MA; Heath PR; Livesey MR; Ning K; Azzouz M; Shaw PJ; Guarracino MR; Whitworth AJ; Ferraiuolo L; Milo M; Hautbergue GM
    Mol Neurodegener; 2021 Aug; 16(1):53. PubMed ID: 34376242
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Downstream Effects of Mutations in
    Dash BP; Freischmidt A; Weishaupt JH; Hermann A
    Int J Mol Sci; 2022 Aug; 23(17):. PubMed ID: 36077049
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting phosphoglycerate kinase 1 with terazosin improves motor neuron phenotypes in multiple models of amyotrophic lateral sclerosis.
    Chaytow H; Carroll E; Gordon D; Huang YT; van der Hoorn D; Smith HL; Becker T; Becker CG; Faller KME; Talbot K; Gillingwater TH
    EBioMedicine; 2022 Sep; 83():104202. PubMed ID: 35963713
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Knowledge-Based Machine Learning Approach to Gene Prioritisation in Amyotrophic Lateral Sclerosis.
    Bean DM; Al-Chalabi A; Dobson RJB; Iacoangeli A
    Genes (Basel); 2020 Jun; 11(6):. PubMed ID: 32575372
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Integrative Analysis of Motor Neuron and Microglial Transcriptomes from SOD1
    Kubat Oktem E; Aydin B; Yazar M; Arga KY
    J Mol Neurosci; 2022 Nov; 72(11):2360-2376. PubMed ID: 36178612
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug Repurposing: A Network-based Approach to Amyotrophic Lateral Sclerosis.
    Fiscon G; Conte F; Amadio S; Volonté C; Paci P
    Neurotherapeutics; 2021 Jul; 18(3):1678-1691. PubMed ID: 33987813
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.